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Abstract 
Bioactivity modification helps Polymethylmethacrylate (PMMA) bone cement to 
reinforce its interfacial adhesion to bone tissues through the chemical bonding of apatite. Since 
Si-OH groups combined with Ca2+ ions have succeeded in inducing apatite formation, more 
combinations of functional groups and active ions are being explored. In this study, Bis[2-
(methacryloyloxy)ethyl] phosphate (B2meP) containing phosphate (=PO4H) groups and 
Ca(CH3COO)2 supplying Ca2+ ion were adopted to investigate the feasibility of equipping 
PMMA bone cement with apatite-forming ability in vitro, more effects under designed contents 
on setting behavior, injectability, contact angle, cytotoxicity and mechanical strength were also 
investigated. Results showed B2meP copolymerized with MMA and became one section of 
PMMA chains, surface =PO4H groups and released Ca2+ ions pushed spherical apatite 
individuals nucleating and agglomerating into layer horizontally, Increasing B2meP content 
lowered the contact angle and the peak temperature, enhanced the cell viability of MC3T3-E1, 
but prolonged apatite forming period. Injectability rates performed a similar trend to setting 
time. Lower adding content and deposited apatite layer contributed to reduce the strength loss 
in soaking. Taking biological performance and other properties into balance, cement added 
with B2meP of 10 wt% in MMA and Ca(CH3COO)2 of 20 wt% in PMMA performed better. 
Key words: PMMA bone cement, Bioactivity modification, Surface =PO4H functional groups, 
Apatite-forming in vitro; Setting behavior; Mechanical Strength 
1. Introduction 
Cement-type biomaterial of PMMA owns similar characteristic of the cements used in 
architecture, the transformation from soft paste to hardened cement during the polymerization 
of methylmethacrylate (MMA) helps to create the characteristic of coherent matrix and 
deformable capacity, which makes the cement easily to be filled into the complex space of 
body parts. Therefore, PMMA bone cement is widely employed as the ideal candidate for the 
treatment of spinal compression fractures or the fixation of joint prosthesis in orthopedic 
surgery [1,2]. Since successful application in clinic, the typical shortcomings of cement itself 
have been exposed, for example, aseptic loosening of the prostheses has been reported in 
certain cases due to the thermal necrosis of bone tissue [3], and it can be ascribed to the 
exothermic polymerization during cement setting. Volume shrinkage and residual stress 
remaining in preparation stage aggravate the cracks formation and propagation [4], which has 
been devoted to the deterioration of mechanical properties, shortened cement serving period in 
vivo [5]. Not only to these, the mechanical interlocking to bone tissues leads PMMA bone 
cement performing poor adhesion [6], which will lower the long-term stability of artificial joint 
prosthesis, raise the potential risk of repetitive operations on patients [7]. 
Bioactivity, i.e. the bone-bonding ability, has been proved more feasible in strengthening 
the bonding at the interface of implants and bone tissues [8,9]. In the early implantation period, 
the chemical bonding instead of physical connection depends on bone-like apatite, it’s a special 
reaction product of bioactive materials and body fluid, whose component and structure are 
similar to that of inorganic mineral phase in natural bone [10]. After that, the bone-like apatite 
layer starts to absorb biological moieties, promote the cellular activities including the 
colonization, proliferation and differentiation by osteoblast stem cells, finally forms new bone 
and achieves the bony adhesion on the implant surface [11]. To PMMA bonce cement, there 
are two mainstream modification designs in equipping apatite-forming ability. First one is that, 
incorporating bioactive materials such as bioceramics [12], bioglass [13], graphene (oxide)-
based composites [14,15] into the powder phase to synthesize the composite-type cement, 
utilizing the bioactivity of additives themselves to induce apatite depositing on cement surface. 
Although the composite cements have shown a tight contact to living bone when implanted 
into body environment, there are still some shortcomings left in the modification scheme itself. 
Most notably, the bioactive particles inside cement matrix lose their original function, apatite 
deposition is only occurred on cement surface where the bioactive particles can be exposed to 
body fluids. Thus, to obtain massive apatite deposits for better affinity performance requires 
high content of the additive, which in turn lead to a worsening on the physical properties of 
PMMA bone cement [16]. Another modification design is inspired from the apatite nucleation 
mechanism on bioglass45S5 reproduced in simulated body fluid (SBF). Si-O-Na components 
released the Na+ ions to form Si-OH group via ion exchange with H3O+, the Si-OH functional 
groups owns the potential to attract Ca2+, HPO42- and OH- ions gathering on surface, and 
released Na+ ions increases the ionic activity product (IAP), both contributes to the nucleation 
of apatite [17]. Besides that, more groups like Ti-OH, Ta-OH, -COOH have been discovered 
to share the same role as Si-OH group [18-20], and the active ions for increasing IAP also 
expands to K+ and Ca2+ ions [21,22]. Under this design thought, the most representative one 
was the combination of “Si-OH groups and Ca2+ ions”, which succeeded in inducing apatite 
depositing on PMMA bone cement, the growth of new bone was also observed on the tibia of 
Japanese rabbit [23]. Besides that, the combination applied on commercialized Zimmers® 
dough-type cement also received higher osteoconductive properties through micro-CT 
observation, the push-out load of 1.6 MPa indicated that modified specimens exhibited stronger 
bonding to bone tissues [24]. 
Except Si-OH groups, the phosphate groups self-assembled on Au substrate performed 
superior performance in inducing apatite deposition [25], being suggested as the next promising 
candidate for bioactivity modification. In this study, the BisP[2-(methacryloyloxy)ethyl] 
phosphate (B2meP) monomer whose chemical structure shown in Figure 1 is added into the 
MMA, which is expected to be polymerized into PMMA main chain to increase the existence 
of =PO4H groups on cement surface. Calcium acetate powder is added into the PMMA to 
control Ca2+ releasing. The purpose is to equip PMMA bone cement with apatite-forming 
ability under the combination of =PO4H functional groups and Ca2+ ions, illustration about the 
role of additives on inducing apatite nucleation is shown in Scheme 1. And the study also put 
emphasis on investigating the effort brought by B2meP content on the setting behavior, apatite 
formation, cytotoxicity and mechanical strength, and final the additive content optimization 
will also be determined based on the balance of in vitro biological performance and standards 
in potential application. 
2. Materials and Methods 
2.1 Materials 
PMMA beads was a commercial product brought from Sekisui Chemical Group (Tokyo, 
Japan), its molecular weights in Mw and Mm were 70,000 and 56,000, respectively, and the 
particle size was in a range of average size of 8.0~31.0 um. Benzoyl peroxide (BPO), 
Methylmethacrylate (MMA), N,N-dimethyl-p-toluidine (DmpT) and Calcium Acetate 
(Ca(CH3COO)2•H2O) were purchased from Wako Regent Company (Tokyo, Japan), Bis [2-
(methacryloyloxy)ethyl] phosphate (B2meP) was ordered from Aladdin Regent Company 
(Kyoto, Japan). Calcium Acetate for cement modification need to be pretreated with the process 
of desiccating Ca(CH3COO)2•H2O at 220 ºC for 2 h then passing through the 44 μm mesh sieve. 
Simulated body fluid (SBF) was prepared following reported protocol [26]. Mouse embryo 
osteoblast precursor (MC3T3-E1) cells were sourced from the Cell Bank of Chinese Academy 
of Sciences in Kunming, Dulbecco's Modified Eagle's Medium with high glucose (DMEM), 
Fetal Bovine Serum (FBS), penicillin/streptomycin solution, sterile Phosphate Buffered Saline 
(PBS) and Cell Counting Kit-8 (CCK-8) were purchased from Gibco Life Technologies (Green 
Island, NY, USA), NaOH and NaCl were offered by Sinopharm Chemical Reagent Co., Ltd 
(Shanghai, China). 
2.2 Cement preparation 
Components for PMMA bone cement modification were divided into 2 parts. To powder 
phase, PMMA beads were blended with pretreated Ca(CH3COO)2 and benzoyl peroxide (BPO) 
as the polymerization initiator. To liquid side, a mixture was composed of MMA, Bis [2-
(methacryloyloxy)ethyl] phosphate (B2meP) and N,N-dimethyl-p-toluidine (DmpT) as the 
polymerization accelerator. Detailed weight fraction and naming for the component is given in 
Table 1, the additives merely replaced PMMA beads or MMA monomer, the contents of BPO 
and DmpT stayed the same, and the sample “B2meP0 + CA0” as the reference copied the 
compositions of commercially available cement CMW® 1, Debuy Synthes Co. Ltd., England. 
The condition for cement preparation was controlled at 23±2 ºC with a relative humidity (R.H.) 
of 50%±10%, and the mixing ratio of powder phase to liquid side was 1: 0.5 (P/L, g/g). 
2.3 Physical properties Measurement 
2.3.1 Setting behavior  
Setting behavior of cement was measured following the guidance of ISO5833-2002 [27]. 
For the testing, a K-type thermocouple probe (Plamic 100Ω) coupled with a counting-type 
thermometer (DT-3891G, CEM-instruments Ltd., Shenzhen, China) was adopted to monitor 
and record the temperature rising in polymerization exothermic process, and the data logging 
interval was set as per second. Measurement procedure could be briefly described as below: 
temperature recording began from the powder and liquid coming into contact. After turning 
into no sticky state, the cement was filled into a cylindrical mold with the size of φ 60×6 ±0.5 
mm2, and the K-type thermocouple probe was placed to the centre of mold to sense the 
temperature on cement surface over setting, and the recording continued until shortly after the 
temperature started to fall. Peak temperature was defined the maximum temperature over the 
setting process, and setting temperature was calculated by as the following formula: 
   ( )1Setting Temp.= Room Temp.+ Peak Temp.
2
                                   (2-1) 
While, setting time was determined as the value that corresponding to the setting 
temperature on the temperature-time curve, which could be deeply illustrated in Figure 2. In 
this study, 4 repetitive measurements were necessary for each cement combination.  
2.3.2 Injectability 
Injectability was performed on cement paste to test the feasibility used in syringe usage. 
10 g of powder was mixed with 5 g of liquid for 30 second, as the mixture turned into paste, a 
20 ml medical sterile syringe in the size of φ1.6 × 30 mm2 was used to extract the paste into 
the chamber to verify its extractability. As another mixture with same components turned into 
no-sticky dough, it was plugged into chamber then extruded out to verify the injectability. 
Injectability rate to each combination was based on 3 repeated tests, and calculated as follow: 
cement weight extruded from the syringeInjectability rate (%) = 100
cement total weight
×                   (2-2) 
2.3.3 Contact angle 
Contact angle measurement was performed on a professional meter (JC2000C, 
POWEREACH, Shanghai, China). Simulated body fluid (SBF) was chosen as the contact 
medium, PMMA bone cement for the measurement was molded into the rectangular sheet of 
10 × 15 × 1 ±0.1 mm3 and polished by 1000# SiC paper at first. Measurement process could 
be briefly described as following: the SBF droplet was taken into photo as naturally dropping 
down to cement surface for 10 second, the contact angle was determined based on the shape of 
droplet in photo using goniometry method. To each sample, three different locations were 
selected.  
2.3.4 Mechanical strength 
Compressive strength measurement was following the requirements of ISO standard 5833 
[27], and it was carried out on the Universal Testing Machine (Autograph AG-1, Shimadzu 
Co., Kyoto, Japan). Testing samples were shaped into the cylinder of φ6×12 ±0.1 mm2. In 
measurement, A 10 KN of compressive load with a crosshead speed of 20 mm/min was 
continuously pressed against the sample until the fracture happened, compressive strength was 
determined using the calculation expression below: 
C 2





                                                                 (2-3)  
where, F was the fracture load, A was the initial cross-sectional area. 7 specimens were 
tested for each set of combination.  
Bending strength was performed on the same machine using three-point test. Testing 
specimens were molded in a beam shape with size of 60×5×4 ±0.1 mm3, and the loading rate 
was set as 5 mm/min. In measurement, the load towards to down was pressed on the middle 
site of beam specimen until the specimen was broken. Bending strength was calculated using 
the formula:  
B 2
F 3 F Lδ =




                                                             (2-4) 
where, F was the load that fracture happened on the load–displacement curve, L was 40 
mm in this study, representing the distance between two end supports. b and h were the width 
and the height of beam specimen, respectively. And each cement formulation was carried on 5 
times of duplication tests. 
2.4 In vitro biological performance assay  
2.4.1 Cytotoxicity  
CCK-8 assay was carried out to determine in vitro cytotoxicity of PMMA bone cements 
through culturing of MC3T3-E1 cells with extracts of cements. The extract preparation needed 
cements being shaped into the φ6×4 ±0.1 mm2 disks in advance. All the disk samples were 
pre-treated with 75% ethanol and PBS for at least 12 h, respectively, subsequently immersed 
into 0.43 ml complete medium according to the cement/medium ratio of 3 cm2/ml, the complete 
medium contained 89 vol% of DMEM, 10 vol% of FBS and 1 vol% of penicillin/streptomycin. 
After 24 h of immersion and filtration, the extract was ready to be used for the next co-culturing. 
MC3T3-E1 cells passaged to the 2nd generation were seeded in a 96-well plate at a cell density 
of 1×105 cells/cm2, each well contained 100 μl of the complete medium. After 24 h incubation 
in a humidified atmosphere of 5% CO2 at 37 oC, the medium was removed and the extract was 
added, MC3T3-E1 cells continued to be incubated under the same condition for another 24 h. 
Then 10 μl CCK-8 reagent was added into each well and incubated additional 2 h, the 96-well 
plate was shifted to a microplate reader (Thermo Multiskan Spectrum, Thermo Scientific, USA) 
for measuring the absorbance of each well at 450 nm (OD450). Cell relative growth rate (RGR) 








×                                                (2-5) 
While ODC and ODB represented the absorbance of control group and blank group, 
respectively. Cytotoxicity level of bone cements were given according to the judgment of ISO 
standard 10993 on RGR results [28]. 
2.4.2 Apatite forming ability in SBF 
Whether PMMA bone cement equipping with apatite-forming ability was assessed in 
simulated body fluid (SBF), the ion concentration of SBF was of Na+ 142.0, K+ 5.0, Mg2+ 1.5, 
Ca2+ 2.5, Cl-  147.8, HCO3- 4.2, HPO42- 1.0 and SO42- 0.5, mmol/L, nearly equal to that of 
human blood plasma. All cements shaped into the size of 10 × 15 × 1 ±0.1 mm3 were polished 
with 1000# SiC paper in advance. Processed cements were soaked into sterile plastic bottles 
filled with 35 ml SBF, then placed in the condition of 37±1 ºC at the interval of 3, 7 and 14 
days. After that, the specimens were removed, rinsed and dried at room temperature.  
2.5 Characterization 
Characterization of modified cements  
Chemical structures of modified cements were characterized by FT-IR spectrometer 
(Tensor 27, Bruker Corporation, German) and 1H-NMR (Bruker Avance 400, Bruker 
Corporation, German). FT-IR spectra was measured from the wavenumber of 400 cm-1 to 4000 
cm-1 under the KBr pellet pressing method, the cements needed to be crushed into powders in 
advance. 1H-NMR spectra were recorded at 400 Hz using CDCl3 as the solvent.  
Characterization of cements after SBF soaking 
Thin-film X-ray diffractometer (MXP3V, MAC Science Ltd., Yokohama, Japan) and FT-
IR spectrometer (FT/IR6100, Jasco Analytical Instruments, Tokyo, Japan) was employed to 
survey new phase on cement surface, TF-XRD pattern was scanned from 20º to 40º in 2θ under 
the scan rate of 0.02º/s, and the wavenumber in FT-IR spectra was set in a range of 500 cm-1 
to 2000 cm-1. Surface morphology of PMMA bone cements after SBF soaking were examined 
by SEM (S-3500N, Hitachi High-Technologies, Tokyo, Japan) combined with EDX 
microanalyzer (EMAX Energy, Horiba Ltd., Kyoto, Japan) after sputter coating a thin film of 
carbon on them. Concentration changes on the elements of Ca and P in SBF were measured by 
ICP-OES (Optima 4300 DV, PerkinElmer, Inc., America). And pH meter (F-23IIC, Horiba 
Ltd., Kyoto, Japan) was introduced to detect the pH value of cement-soaked SBF under the 
temperature of 37±1 ºC. 
2.6 Statistical analysis 
All results from repetitive experiments were expressed as mean ± standard deviation (SD). 
Statistical differences on means were analyzed by using one-way analysis of variance 
(ANOVA) with Turkey test method on SPSS 22.0, and the significance level was set as p value 
< 5%. 
3. Results 
3.1 Chemical structure analysis 
FT-IR spectra of modified samples, CA powder and origin cement were shown in Figure 
3. The absorbances at 1612 cm-1, 1582 cm-1 were assigned to asymmetric stretching vibrations 
of COO- groups, and absorbances at 1026 cm-1, 952 cm-1, 676 cm-1 were assigned to the 
stretching vibrations of C-O group, symmetric bending vibrations of C-CH3 and bending 
vibrations of COO- group, respectively. Those characteristic absorbances belonging to 
Ca(CH3COO)2 were also detected on the spectra of “B2meP30 + CA 20” sample (comparison 
by blue dash line), and showed no obvious changes on wavenumbers, which reflected that CA 
powder indeed existed in cement matrix, but it was not involved in MMA polymerization to 
form chemical bonding with other components. Taking “B2meP0 + CA0” sample as the control, 
its absorbances and corresponding wavenumbers were almost same as those of sample 
“B2meP30 + CA0” and “B2meP30 + Ca20”, which was speculated that B2meP was hard to be 
detected on FT-IR spectra, since B2meP and PMMA shared similar chemical groups, and the 
P-O stretching was hidden by peak overlapping. To further investigate whether B2meP additive 
in the PMMA matrix, 1H-NMR spectra was employed and the comparison between “B2meP0 
+ CA0” and “B2meP30 + CA0” was shown in Figure 4. H signal (d) at the chemical shift of 
4.2-4.4 was assigned as the group of -(CH2)2- of B2meP, it was only detected on the sample of 
“b2meP30 + CA0”, that proved that B2meP successfully copolymerized with MMA, and the 
copolymer of MMA-B2meP displayed the structure formula as speculated in Scheme 1. 
Moreover, the integral value of H signal from -(CH2)2- group was 1.81 shown on the inset, 
while the H signal assigned to C=CH2 groups owned integral values of 0.47 and 0.45 at the 
chemical shift of 6.1~6.15 and 5.55~5.60, respectively. The integral value for -(CH2)2- groups 
from B2meP monomer was summed to 0.92. Difference of 0.89 (1.81-0.92) was attributed to 
the double bond of C=CH2 from B2meP being engaged in polymerization reaction, further 
meant that over half of B2meP copolymerized with MMA, there was still unreacted MMA 
remained in cement matrix. 
3.2 Setting behavior 
Peak temperatures and setting times of cements modified with B2meP, CA or their 
combinations were listed in Table 2. It needed to be pointed that, no temperature rising was 
detected on the samples modified only with B2meP, the dough state was standing for at least 2 
h. According to the definition of setting, these cements were categorized as unset cement, and 
required longer setting time. Compared to the reference sample  of “B2meP0 + CA0”, all the 
modified cements performed significantly lower peak temperature (p<0.05), and to the samples 
whose designed CA content was 20%, peak temperature showed a decline trend as increasing 
the content of B2meP, which contributed to preventing the thermal necrosis of bone tissue. 
Same comparison on the setting time, it was found that the additives and their combinations 
played more complicated roles, adding CA or B2meP alone significantly prolonged cement 
setting (p<0.05), considering the unset state was the extremity of setting time. While B2meP 
combined with CA made the setting of modified cements become significantly shortened 
(p<0.05), the fastest setting was detected on sample of “B2meP20+CA20”, and any change on 
B2meP content caused a prolonging of setting time. To clinical requirements of ISO standard 
5833, the lower limit made two samples of “B2meP20+CA20” and “B2meP30+CA20” fail to 
satisfy the syringe usage. 
3.3 Injectability 
Injectability measurement was to verify whether bone cements after additives added could 
be used in syringe type, and the results were concluded in Figure 5a,b combined with Table 
3. Photographs in Figure 5b showed all cement pastes were successfully extracted into 
chamber and extruded out, indicating that the modified cements still shared the same good 
extractability and extrudability as the reference sample of “B2meP0 + CA0”. And calculated 
injectability rates in Table 3 revealed more details: only one additive either B2meP or CA, and 
B2meP10 combined with CA20 brought no obvious changes, the rest of cements performed 
significantly lower rates (p<0.05) compared with the original one, in which the lowest 
injectability rate of 74.28% ± 4.33% was detected on sample of “B2meP20 + CA20”. 
Injectability rate played a similar trend to that of the setting time, which implied there was a 
relationship between them.  
3.4 Contact angle  
Contact angle was one of the indicators in judging the hydrophilia of PMMA bone cement, 
Table 4 listed the average values, which were measured based on the optical photos of SBF 
droplets shown in Figure 6. “B2meP0 + CA0” cement presented a contact angle of 74.5º ± 
1.3º, below 90º meant PMMA bone cement itself was able to be wetted by SBF. No matter 
adding both or B2meP alone, the contact angles of modified cements were significantly 
reduced (p<0.05) via the comparison with reference sample. Among the cements added with 
both additives, “B2meP30 + CA20” sample showed the lowest contact angle of 45º ± 4.4º, 
while adding B2meP alone case put the highest adding content of 30 wt% owning the lowest 
contact angle of 15º ± 3.6º, two cases performed the same trend, the contact angle decreased 
with the increase of B2meP content, potentially implied that B2meP participated in the 
polymerization reaction and embedded into the main chain of PMMA, so that the hydrophilic 
=PO4H groups were resided on cement surface and helped to build better wettability. Figure 6 
is the visual images of SBF droplets on PMMA bone cement surface. The shape of droplet 
directly showed the variation trend of contact angle with the additive content. In addition, the 
difference on contact angle was also resulted from the droplets size, the evidence was 
discovered from the comparison of sample “B2meP0 + CA0” and “B2meP30 + CA0”.  
3.5 In vitro cytotoxicity  
Figure 7 reflects the effects of cement itself, additives and related adding amounts on in 
vitro toxicity of MC3T3-E1 cells. According to the standards of ISO 10993, the cell viability 
values were all beyond 80%, which demonstrated that all prepared cements were non-toxic, 
owned potential biological safety. The reference sample of “B2meP0 + CA0” performed a cell 
viability lower that 100%, the reason could be ascribed to the incompletely polymerized MMA, 
since its hazard had been proved to physiological environment [29]. As residual MMA was 
released from cement, its toxicity resulted in the cells hard to prolife in the extract. In contrast, 
all modified cements owns a significant higher cell viability that that of reference sample 
(p<0.05), which indicated that the additives and their combination played a positive role in 
promoting cell proliferation, and the positive role to cell viability became enhanced with 
increasing the content of B2meP, especially on the sample added with 20% or 30% of MMA, 
the cell proliferations showed a statistical significance (p<0.05) compared to other modified 
cements. 
3.6 Induced apatite deposition 
TF-XRD patterns of bone cements after soaking in SBF for the interval of 0, 3, 7, 14 days 
were displayed in Figure 8. From the patterns, Distinct diffraction peaks labeled with black-
circle were appearing on the samples of “B2meP0 + CA20”, “B2meP10 + CA20” and 
“B2meP20 + CA20”. According to the identification of JCPDS Card no. 09-0432, these labeled 
peaks located at about 26º and 32º in 2θ were assigned as the (002) diffraction and an 
overlapping diffraction of (211), (112) and (300) of apatite, respectively, and lower intensity 
and wider peak shape indicated that deposited apatite was a lower crystallinity hydroxyapatite. 
More B2meP added in cement brought about the period postponement in first appearance of 
apatite, when B2meP adding amount reached to 30wt% of MMA liqiud, apatite deposition was 
extended to 14 days later due to no apatite peaks were detected. To the samples added with 
B2meP alone, 14 days soaking was unable to induce apatite depositing, which implied that 
merely relying on = PO4H functional groups on bone cement surface were not sufficient to 
succeed in inducing apatite nucleation without additional Ca2+ sources. 
To further figure out the morphology and constituents of deposited apatite, SEM 
combined with EDX were utilized, and the characterization results were shown in Figure 9. 
On the surface of “B2meP0 + CA20” sample, continuous nucleation of new apatite mainly 
occurred on the one had already deposited, which resulted in the deposits agglomerated to each 
other along longitudinal orientation, and performed a shape that close to the island. Apatite in 
island shape was similar the morphology that obtained from the cement incorporated with bio-
ceramics like nano-HA [30]. Such morphology features further proved apatite deposition was 
restricted to the sites where bioactive particles were liable to expose to SBF. While after another 
additive B2meP was added into cements, more apatite was nucleated in SBF soaking, and the 
quantity of deposits was increased with the adding content. Due to the heterogeneous 
nucleation brought by surface functional groups of =PO4H, apatite deposits were relatively 
uniformly distributed on cement surface, and the agglomeration changed to horizontal direction, 
which led deposits to extending into the layer shape. On the magnified SEM images, it was 
clear to see that apatite individual was sphere-like, and the microsphere size appeared to be 
slightly decreased under the increase of apatite nucleation amount, apatite individual spheres 
owned a size range of 5~22 μm. EDX spectra showed that apatite deposits mainly contained 
Ca, P elements, and the calculated Ca/P atomic ratios on the corresponding modified cements 
were 1.60, 158 and 1.62, respectively. All ratios were lower than the stoichiometric ratio of 
1.67 of Ca10(PO4)6(OH)2, apatite formed in SBF was judged as one sort of Ca-deficient 
hydroxyapatite [31], that was in accordance with the result concluded from the XRD patterns. 
FT-IR spectra shown in Figure 10a,b was detected on cement surface before and after 
soaking, respectively, which was used to deeply exploring more detailed radical groups of 
modified cements and deposited apatite. Radical groups listed in Table 5 were corresponding 
to those number-marked peaks appearing on the FT-IR spectra and considered to be the 
characteristics of PMMA. While the intrinsic peaks belonging to B2meP and Ca(CH3COO)2 
were hard to be detected due to the overlapping of peaks. Comparison between Figure 10a,b 
manifested that, SBF soaking without apatite deposition never produced obvious changes on 
the FT-IR spectra, the new peaks marked with black triangle were identified as the typical P‒
O stretching, specifically including P-O ν4 vibration at 550 and 600 cm-1, P-O ν1 vibration at 
950 cm-1, P-O ν3 vibration at 1020 cm-1 [32]. P‒O peaks was derived from the deposited apatite 
through the confirmation from XRD patterns and SEM images. And the difference in FT-IR 
spectra on the samples of “B2meP0 + CA20”, “B2meP10 + CA20” and “B2meP20 + CA20” 
depended on the morphology of apatite shown in Figure 9, to “B2meP0 + CA20” cement, 
island shape apatite deposition caused cement surface remaining much of empty region, thus 
the FT-IR spectrometer was able to observe both PMMA and apatite. Once layered apatite 
covered on bone cement, there were only the characteristic peaks of apatite left, shown on the 
samples of “B2meP10 + CA20” and “B2meP20 + CA20”. 
3.7 Ca, P concentrations changes in SBF  
Concentration changes of Ca and P elements in SBF, corresponding pH values over the 
cement soaking time are displayed in Figure 11a to 11c, respectively. For Ca element shown 
in Figure 11a, its element concentration was an outcome of the dissolve-out amount of 
Ca(CH3COO)2 deduct the consumption for apatite, the overall trend of Ca concentration was 
ascending with the extension of soaking period, higher concentration under the same soaking 
period was found on the sample with higher weight proportion of BisP, which implied that the 
loose matrix of PMMA bone cement changed by B2meP was liable to push more 
Ca(CH3COO)2 dissolution. For P element in Figure 11b, raising on its concentration was found 
on all =PO4H containing cements within 3 day of soaking, concentration rising was born of 
B2meP releasing, meant small part of B2meP was not involved in the polymerization reaction, 
while the next dropping of concentration on samples of “B2meP10 + CA20” and “B2meP20 + 
CA20”was resulted from the consumption for apatite nucleation, changes on P concentration 
over soaking period reflected whether there were apatite formation on cement surface, which 
was in accordance with the changes on TF-XRD patterns. Tendency of the pH variation of SBF 
was more complicated, the dissolution of alkaline Ca(CH3COO)2 and the release of acidic 
B2meP created the increase and the decrease of pH, respectively. Therefore, slight increase of 
pH on the samples of “B2meP0 + CA20” and “B2meP10 + CA20” implied that the effort 
produced by sufficient Ca(CH3COO)2 dissolution exceeded that brought by a small part of 
B2meP releasing. Continues dropping of pH was not only attributed to the consumption of OH-, 
B2meP releasing under the high adding content became the main source and produced deeper 
dropping of pH, which was supported by the sample of “B2meP30 + CA20”.  
3.8 Mechanical performance  
Figure 12a, b depicts the variations on compressive strength and bending strength of 
cements under additive contents and soaking periods, respectively. In Figure 12a, additives 
didn’t bring a universal decline on the compressive strength to all modified cements before 
soaking, significant difference (p<0.05) was only detected on the sample whose B2meP content 
was increased to 30wt% of MMA, compared to the reference sample of “B2meP0 + CA0”. 
After soaking, cements showed a lower compressive strength, but the decline in strength was 
not continued to the samples equipped with apatite-forming ability, compressive strength 
measured at 7 days and 14 days soaking were close to each other. Among all modified cements, 
the sample of “B2meP10 + CA20” owned the top average compressive strength, the detailed 
values were 97.7 ± 3.0 MPa and 98.4 ± 5.2 MPa under 7 days and 14 days soaking, respectively. 
In Figure 12b, bending strength displayed the variations similar to that of compressive strength: 
the decline still happened, but was not continued on the cements induced apatite forming. To 
the sample of “B2meP30 + CA20”, B2meP content in 30wt% combined with 14 days soaking 
caused its bending strength failing to meet the lower limit of ISO 5833. In addition, "B2meP10 
+ CA20" sample still performed the top average bending strengths no matter being soaked for 
7 days or 14 days. ANOVA analysis indicated that the top strengths either in compressive or 
in bending were significantly different from others, the differences might be produced by the 
lower adding amounts and the deposited apatite layer, according to the comparison and 
estimation based on the SEM images in Figure 9 and the concentration changes in Figure 
11a,b. In brief, although soaking caused the mechanical strengths of modified cements lower 
than those of the reference sample, but to the cements with apatite-forming ability, especially 
the sample of “B2meP10 + CA20", the strength values were beyond the lower limit of ISO 
5833, which made them still own the qualification for clinical treatment.  
4. Discussion 
Setting, a polymerization process that liquid MMA was transformed into solid PMMA, 
relies on the benzoyl radicals and benzoyl anions, the decomposed products from a reduction-
oxidation reaction between BPO and DmpT. Just like other additives of quaternized chitosan 
or bone marrow [33,34], Ca(CH3COO)2 was independent to the PMMA/MMA reaction system, 
their role in setting acted like barrier, which reduced the opportunity for contact between 
benzoyl radicals and MMA, further brought prolonged setting process due to the contact 
determined the broken of C=C double bond for initiating the formation of PMMA chains. 
Prolonged setting time was beneficial for the blood or fluid to carry more heat in advance 
through the cycle flowing, a lower exothermic temperature had been recorded when cement 
setting was measured at the human tibia in vivo [35]. Based on the reaction mechanism shown 
in Figure 13, since one by-product was H+, the polymerization process was affected by the 
acidity of liquid phase. To most bioactive ceramics [13, 36], their neutral or alkalescent nature 
had almost no effect to the acidity of PMMA/MMA system, but the liquid B2meP monomer 
was more acidic, it brought higher acidity to the reaction system, and resulted in the oxidized 
benzyol radical was difficult to be converted into neutrality by proton separation, further 
extremely delayed the polymerization. When Ca(CH3COO)2 and B2meP were both added into 
PMMA cement, the alkalescence of Ca(CH3COO)2 could partly neutralize the acidity of 
B2meP and pushed the reaction system back to its normal pH range. In some sense, the 
neutralization meant both roles of Ca(CH3COO)2 and B2meP in prolonging the setting time 
were offset to each other, BPO/DmpT only served residual portion of PMMA/ MMA, therefore, 
setting time of modified cements became shortened. More about the negative role of B2meP 
could be further verified when the powder additive was changed as Ca(OH)2. Except the 
influence of acidity of additive in reaction system, more mechanism should be clarified from 
the point that free electrons transfer on the benzoyl radicals and benzoyl anions [37,38].  
To injectability, good extractability and extrudability of modified cements implied that 
the factors like designed amounts, CA powder size and B2meP monomer viscosity showed 
almost no efforts. More crucial role in determining the significant differences on injectability 
rates between cements was attributed to the setting time, since setting was a process of 
increasing the viscosity and decreasing the movability of cement paste [39]. Faster setting 
accelerated PMMA chains propagation and made part of cement paste remained into syringe 
chamber, which created an injectability rate trend similar to that of setting time. 
Lower contact angle brought better hydrophila to cement, it conducted to improving the 
biological performance, especially in the deposition of apatite. Except the hydrophilic role of 
=PO4H functional groups on cement surface, the factors in decreasing the contact angle also 
included the cement setting behavior under additives. Poor cementation to the PMMA beads 
found on the unset samples, resulted in the intrinsically compact structure being worsened into 
loose, the loose structure coupled with the pores was liable to absorbed a part of the SBF droplet, 
which decreased the droplet size to make deeper contribution in reducing the contact angle. 
Adding more B2meP resulted to the decrease of the contact angle, while it supported to create 
a more suitable physiological environment for cell proliferation. Rising trend on the cell 
viability of MC3T3-E1 cells was attributed to the release of additives, noticeably occurred on 
the cement with more loose structure. In short, setting under the high content of B2meP and 
CA produced the loose structure on cement, which was beneficial to obtain better hydrophila 
and proliferation environment.  
Although better hydrophila was beneficial for apatite deposition, SBF soaking results 
indicated that more about PMMA bone cement with apatite-forming ability was determined by 
the role of additive and related adding content. Inducing apatite nucleation was failed when 
cement was modified only with B2meP, one reason was speculated as dissociative Ca2+ ions in 
SBF was insufficient, they could not be transformed into precipitation under the attraction of 
=PO4H functional groups, increasing more Ca2+ ions on surface was able to be achieved by 
adding additional calcium source into cement, which was proved by the case of incorporating 
CA alone. Success in inducing apatite deposition on cement surface was attributed to the 
intrinsic characteristic of PMMA cement as a carrier used in antibiotics delivery [40], but the 
nucleation and growth was restricted to the location where Ca(CH3COO)2 particles were 
exposed to SBF. When both B2meP and CA were added, apatite morphology changed into the 
layer composed of individual microspheres, the coaction of Ca2+ ions and =PO4H functional 
groups in determining the generation of apatite layer was the same to the illustration shown in 
Scheme 1, Ca2+ ions supplied by high solubility (33.2g/100 ml in water at 40 oC) of 
Ca(CH3COO)2 increased the supersaturation degree with respect to apatite, =PO4H groups on 
cement surface initiated the heterogeneous nucleation by evenly attracting Ca2+ ions. Unlike 
the reports that cements added with bioglass of SiO2-Na2O-CaO-P2O5-B2O3-Al2O3-Ag2O or 
fluorapatite needed 28 days of soaking in inducing apatite deposition [41,42], the combination 
of B2meP and CA could shorten apatite forming period to 3 days. And a shorter 
biomineralization period was beneficial for lowering the response from immune system, 
especially in forming fibrous capsule and wrapping over the implant. It also contributed to 
prevent the wounds from stepping into the chronic inflammation stage, ensuring that bone 
trauma, defects and nonunion could be repaired and healed normally [43]. In addition, 
compared to the apatite agglomerating in longitudinal orientation, apatite horizontal spreading 
into layer fully covered in the gap between cement and bone tissues to form a whole connection 
on both sides, which was expected to further enhance the interface bonding in vivo at the early 
implantation stage. 
B2meP was necessary to obtain apatite layer, but increasing its content also resulted in 
the postponement of apatite-forming period. According to the ionic activity product (IAP) of 
apatite in SBF [44] expressed below:  
( ) ( ) ( )2+ 3- -
4
610 22+ 10 3- 6 - 2
4 Ca PO OH
IAP = [Ca ] [PO ] [OH ] γ γ γ                             (4-1) 
where [] represented the activities of corresponding ions, and (γ) was the relative activity coefficients, 
usually identified as the empirical value of 0.36, 0.06 and 0.72 under the physiological environment, 
respectively. 
Factors in determining the formation of apatite in this research were addressed as the 
concentrations of element Ca and P, and the pH of SBF (reflecting the concentration of OH- 
ion). Concentration changes and pH trends over soaking in Figure 11 indicated that, the 
activities of Ca2+ and PO43- ions was enough even excessive, but sustained declined pH lowered 
the supersaturation degree of apatite, and bigger decline was following the increase of B2meP 
content, especially on the sample of “B2meP30 + CA20” at the 3rd day soaking . Rapid decline 
triggered by unreacted B2meP release made modified cement fail to induce apatite nucleation.  
Enhanced mechanical strength of modified bone cement relied on additives, while CA in 
this study lacked of excellent mechanical performance like graphene (-oxide) or MWCNT 
[15,45], much less another B2meP was liquid organic monomer. According to published 
researches, reasons for strength loss of bone cement under bioactivity modification could be 
summarized into three categories: first one was the additives themselves, some of them were 
incapable to make up the strength loss from the replaced cement part [46]; the second was 
ascribed to the dissolution or release of additives, it produced pores in the matrix during 
soaking, which brought a further worsen to strength [23]; and third one was pointed to the 
deposited apatite, once filling into the pores, it was able to alleviate the strength deterioration 
via preventing deeper loss of additives [47]. Back to compressive strength shown in Figure 
12a, statistical difference between sample “B2meP0 + CA0” and “B2meP30 + CA20” 
indicated that B2meP content in the lower range of 0~20wt% didn’t obviously brought obvious 
decrease on modified cements, More significant strength decline were detected on the same 
sample after SBF immersion. Therefore, the reason for strength loss in our study could be 
verified as the dissolution or release of CA and B2meP. Although soaking produced inevitable 
strength deterioration, there was still significant difference of strength on the bone cements 
equipped with apatite-forming ability. Difference on compressive or bending strength could be 
traced to the deposited apatite, especially to the morphology. Compared with island shape 
apatite, the layer apatite composed of spherical individuals owned a potential of alleviating the 
strength loss, its role was similar to the apatite filled into pores mentioned above, which was 
able to prevent the drain of additives.  
Consequently, bioactivity modification under the combination of =PO4H functional 
groups and Ca2+ ions has successfully equipped PMMA bone cement with apatite-forming 
ability. The great advantage of combination modification is any materials containing functional 
groups or active ions can be selected as additives to explore the feasibility of inducing apatite 
nucleation, and there is no requirement that the additives themselves must be bioactive. Besides 
that, the addition of organic monomer in MMA is independent to that of calcium salt in PMMA 
powders, any changes of amounts on either side produced more combinations and variations 
on cement properties, especially for pushing mechanical modulus of modified cement close to 
the characteristic of bone. To satisfy the long-term stabilization of implantation, bioactivity 
modification on PMMA bone cement also needs to match the application standard of ISO 5833. 
Taking apatite-forming ability and clinical requirements into balance consideration, the 
additive contents of Ca(CH3COO)2 and B2meP in PMMA/MMA system were 20wt% and 
10wt%, respectively. Modified bone cement is nontoxic, owns 314 s of setting time, 70.4 oC 
of peak temperature, 94.27% of injectability rate, 97.7 MPa of compressive strength and 59.1 
MPa of bending strength after 14 days soaking, apatite layer composed of spherical individuals 
can be deposited within 3 days, shorter apatite-forming period is expected to play positive role 
in reinforcing the adhesion between cement and bone at the early implantation stage. 
5. Conclusion 
PMMA bone cements equipped with in vitro bioactivity in terms of inducing apatite 
deposition have been successfully developed under the combination of B2meP and 
Ca(CH3COO)2. Coaction of phosphate (=PO4H) functional groups and Ca2+ ions pushed the 
spherical apatite individuals horizontally spreading into layer, while increasing B2meP content 
brought the postponement to apatite forming period. Both additives lower the exothermic peak 
temperature and contact angle. Setting time performed the similar trend as injectability rates 
under the same additive contents. Cement strength depends on the additives contents and 
formed apatite morphology, lower adding content shows little loss of strength, and layered 
apatite is beneficial to alleviate the additive release over soaking. Comprehensive consideration 
based on all properties tells that, 10 wt% of B2meP and 20 wt% of Ca(CH3COO)2 have built 
PMMA bone cement with non-toxicity, apatite-forming ability, the setting behavior, 
injectability and mechanical strength satisfied for orthopedic application. 
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Figure 5. (a) powder, liquid and cement paste for injectability measurement from left to right; (b) Typical 







































   
   
   

















Figure 11. Concentration Changes of the Ca (a), P (b) elements in SBF and the pH variation (c) following 











Figure 12. Variations on compressive strength (a) and bending strength (b) of bone cements under designed 
















Table 1. Detailed components of powder and liquid for examined combinations 
CA# 
Powder components (wt%) 
B2meP# 
Liquid components (wt%) 
PMMA BPO CA MMA DmpT B2meP 
0 97.1 2.9 0 
0 99.2 0.8 0 
10 89.2 0.8 9.93 
20 77.7 2.9 19.4 
20 79.4 0.8 19.8 
30 69.4 0.8 29.8 





Table 2. Setting behavior of examined cements based on the combinations  
Setting Behavior 
Cement component 
 B2meP0 B2meP10 B2meP20 B2meP30 
Peak temperature 
(ºC) 
CA0 82.3 ± 3.0 − − − 
CA20 76.5 ± 1.8a 70.4 ± 1.4b 68.9 ± 1.5b 63.5 ± 2.8d 
Setting time (s) 
CA0 361 ± 25 ∞ ∞ ∞ 
CA20 431 ± 29a 314 ± 4b 194 ± 11c 257 ± 9d 
−: No rising in temperature, ∞: viewed as an unset cement; 
a: Significantly different from B2meP0+CA0; 
b: Significantly different from B2meP0; 
c: Significantly different from B2meP0 and B2meP10; 
d: Significantly different from B2meP0, B2meP10 and B2meP20; 











Table 3. Injectability rates of cements under designed additives contents 
 Cement component  B2meP0 B2meP10 B2meP20 B2meP30 
Injectability 
rate /% 
CA0 96.82 ± 1.55 95.24 ± 1.54 96.23 ± 1.18 95.47 ± 0.73 
CA20 97.12 ± 1.18 94.27 ± 1.34b 74.28 ± 4.33c 85.37 ± 2.36d 
a: Significantly different from B2meP0+CA0; 
b: Significantly different from B2meP0+CA20; 
c: Significantly different from B2meP0 and B2meP10; 








Table 4. Contact angles of cements under designed contents of B2meP and CA 
 
Cement component 
 B2meP0 B2meP10 B2meP20 B2meP30 
Contact Angle /º 
CA0 74.5 ± 1.3 32.3 ± 2.6 b 17.8 ± 1.7c 15 ± 3.6c 
CA20 64.8 ± 2.5a  62.8 ± 2.0a 56.1 ± 1.3c 45 ± 4.4d 
a: Significantly different from B2meP0+CA0; 
b: Significantly different from B2meP0; 
c: Significantly different from B2meP0 and B2meP10; 





























 Wavenumber (cm-1) Combination Functional groups 
1 1723 C=O Carbonyl C=O 
2 1483 C-H α-methyl (CH3) 
3 1280 C-H α-methyl (CH3) 
4 1244 C-O -O-C=O 
5 1205 C-H CH chains 
6 1143 C-C C(CH2)n chains 
7 1060 C-O -O-CH3 
8 984 C=C RHC=CH2 
9 843 C=O RC=OOCH3 
10 752 C-H -(CH2)-  
